( OTC-BB:AEMD )

News from aethlon medical, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

16:15 ET Aethlon Medical Announces Fiscal 2016 Results

Aethlon Medical, Inc. (Nasdaq: AEMD), a leading developer of immunotherapeutic technologies to combat infectious disease and cancer, today...


Jun 28, 2016, 09:15 ET Aethlon Medical Announces $12.5 Million At The Market Program

Aethlon Medical, Inc. (the "Company") (Nasdaq: AEMD), a leading developer of immunotherapeutic technologies to combat infectious disease and...


Jun 27, 2016, 09:45 ET Aethlon Medical Joins Russell Microcap® Index

Aethlon Medical, Inc. (Nasdaq: AEMD), announced today that it has been added to the Russell Microcap® Index.  The annual reconstitution...


Jun 27, 2016, 09:15 ET Aethlon Medical to Host Fourth Quarter and Full Year Fiscal 2016 Investor Call On June 29, 2016

Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that it will host its Fourth Quarter and Full Year Fiscal 2016 investor conference call and...


Jun 22, 2016, 09:15 ET Aethlon Medical Set To Join Russell Microcap® Index

 Aethlon Medical, Inc. (Nasdaq: AEMD), announced today that it has been added to the preliminary list of new additions to join the Russell...


Jun 14, 2016, 10:28 ET Aethlon Medical Announces Issuance Of Exosome Capture Patent

Aethlon Medical, Inc. (Nasdaq: AEMD), announced today that U.S. Patent Number 9,364,601 (the "601 Patent"), related to methods for capturing an...


Jun 06, 2016, 09:30 ET Aethlon Medical To Present Cancer And Infectious Disease Initiatives, As Well As Chronic Traumatic Encephalopathy (CTE) Candidate Biomarker Discovery At Tomorrow's BIO International Convention

 Aethlon Medical, Inc. (Nasdaq: AEMD), announced today that Jim Joyce, Chairman and CEO, will be presenting tomorrow (June 7th) at the BIO...


Jun 01, 2016, 09:30 ET Aethlon Medical To Present At 2nd Annual Sachs Associates Immuno-oncology: BD&L And Investment Forum On June 3, 2016

Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at the 2nd Annual Sachs Associates...


May 04, 2016, 09:30 ET Aethlon Medical's Exosome Sciences Announces Production of ELLSA Exosome Isolation Platform

 Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc., (Nasdaq: AEMD) announced today that it will initiate...


May 02, 2016, 08:45 ET Aethlon Medical (AEMD) CEO Note: Hemopurifier Clinical Progression, USA Today on the Next Zika, Combating Bioterror & Pandemic Threats

 Aethlon Medical, Inc. (Nasdaq: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. At present, we are...


Mar 31, 2016, 09:30 ET Aethlon Medical Discloses Hemopurifier® Clinical Trial and Manufacturing Advancements

Aethlon Medical, Inc. (Nasdaq: AEMD), reported that the recently appointed principal investigator of its FDA approved clinical study in Houston,...


Mar 30, 2016, 09:30 ET Aethlon Medical, Inc. Reports Annual Meeting Results

Aethlon Medical, Inc. (Nasdaq: AEMD), today reported the results of its Annual Meeting of Stockholders completed on March 29, 2016 in San Diego,...


Mar 09, 2016, 06:30 ET Aethlon Medical To Present At Roth Capital Partners 28th Annual Growth Stock Conference On March 16, 2016

 Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at the ROTH Capital Partners 28th...


Feb 25, 2016, 08:30 ET Aethlon Medical's Exosome Sciences Announces the Publication of Preliminary Findings of a Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) During Life

 Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. (Nasdaq:AEMD) and investigators at Boston University...


Feb 18, 2016, 09:30 ET Aethlon Medical To Present At 4th Annual Sachs Cancer Bio Partnering & Investment Forum On February 24, 2016

 Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at the 4th Annual Sachs Cancer Bio...


Feb 05, 2016, 09:32 ET Aethlon Medical to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference on February 10, 2016

Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at Source Capital Group's 2016...


Feb 04, 2016, 16:10 ET Aethlon Medical Announces Fiscal 2016 Third Quarter Results

 Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...


Feb 03, 2016, 09:30 ET Aethlon Medical Announces Dengue Virus Study Approval, Chikungunya Virus Capture Data and Completion of U.S. Principal Investigator Training

 Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that a human treatment study entitled: "A Clinical Safety Study of the Aethlon...


Feb 01, 2016, 09:30 ET Aethlon Medical to Present at the 18th Annual BIO CEO & Investor Conference

Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that Jim Joyce, Chairman and CEO, will be presenting at the BIO CEO & Investor Conference...


Jan 29, 2016, 09:30 ET Aethlon Medical To Host Third Quarter Fiscal 2016 Investor Call on February 4, 2016

 Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...


Jan 12, 2016, 09:00 ET Aethlon Medical's Exosome Sciences To Participate In Clinical Research Study To Diagnose Chronic Traumatic Encephalopathy (CTE)

 Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. (Nasdaq:AEMD), announced today that it has agreed to...


Nov 16, 2015, 16:01 ET Aethlon Medical Announces Fiscal 2016 Second Quarter Results

 Aethlon Medical, Inc. (Nasdaq:AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...


Nov 10, 2015, 09:30 ET Aethlon Medical to Participate in the IN3 Medical Device 360 Summit

 Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today...


Oct 26, 2015, 09:30 ET Aethlon Medical To Host Second Quarter Fiscal 2016 Investor Call on November 16, 2015

Aethlon Medical, Inc. (Nasdaq: AEMD), the pioneer in creating affinity biofiltration devices to treat life-threatening diseases, today announced...


Sep 28, 2015, 14:45 ET Aethlon Medical Extends Contract with the Defense Advanced Research Projects Agency

 Aethlon Medical, Inc. (Nasdaq: AEMD), today announced that it has entered into an extension of its contract with the Defense Advanced Research...